Institute of Cancer Research http://www.icr.ac.uk The Institute of Cancer Research is one of the world’s leading cancer research organisations and cancer charities. In partnership with The Royal Marsden NHS Foundation Trust, The ICR specialises in cancer diagnosis, cancer treatment and cancer education Fri, 17 May 2013 19:08:59 +0100 en hourly 1 Statement about BRCA genetic research and testing http://www.icr.ac.uk/press/press_archive/press_releases_2013/23736.shtml Tue, 14 May 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23736.shtml Statement from the ICR about BRCA genetic research and testing, in the light of the announcement by Angelina Jolie that she has had a double mastectomy to reduce her BRCA1-associated risk of developing breast cancer. Large study identifies nine new genomic regions linked to testicular cancer http://www.icr.ac.uk/press/press_archive/press_releases_2013/23735.shtml Mon, 13 May 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23735.shtml A study from the ICR involving over 2,000 men has identified nine new regions of the genome associated with testicular cancer. Timing of Hodgkin lymphoma radiotherapy to women’s first period critical for breast cancer risk http://www.icr.ac.uk/press/press_archive/press_releases_2013/23734.shtml Fri, 10 May 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23734.shtml ICR scientists find radiotherapy near a woman's first period increases breast cancer risk, but pregnancy doesn't increase danger. New DNA blood test could increase access to Herceptin http://www.icr.ac.uk/press/press_archive/press_releases_2013/23716.shtml Wed, 1 May 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23716.shtml ICR scientists believe a new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable biopsies. A double-pronged attack on testicular seminoma http://www.icr.ac.uk/press/press_archive/press_releases_2013/23715.shtml Fri, 26 Apr 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23715.shtml Giving patients a single dose of chemotherapy alongside radiotherapy could improve outcomes for patients with a type of testicular cancer, a new study by The Institute of Cancer Research, London, suggests. New Alliance to develop programme of lung cancer trials covering population of six million http://www.icr.ac.uk/press/press_archive/press_releases_2013/23710.shtml Thu, 25 Apr 2013 00:01:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23710.shtml Leading research institutions and hospitals across London today (Thursday, 25 April) unite to transform the care of lung cancer with plans to invite patients over a population of six million into a pioneering new programme of clinical trials. Identical twins’ genes reveal the ‘silent beginnings’ of leukaemia. http://www.icr.ac.uk/press/press_archive/press_releases_2013/23676.shtml Mon, 8 Apr 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23676.shtml A unique study sequencing the entire genomes of identical twins with leukaemia has identified the first mutations sparking the disease, which could be ideal targets for new cancer drugs. Scientists find that prostate cancer patients with BRCA2 mutations require urgent treatment http://www.icr.ac.uk/press/press_archive/press_releases_2013/23685.shtml Mon, 8 Apr 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23685.shtml Men with the faulty gene who develop prostate cancer need immediate surgery or radiotherapy, as their disease is more aggressive than other types, an ICR study has found. ICR scientists present at AACR conference http://www.icr.ac.uk/press/press_archive/press_releases_2013/23674.shtml Sun, 7 Apr 2013 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23674.shtml Promising results of clinical trials and the future direction of cancer research are amongst the topics that ICR scientists have been discussing at the American Association for Cancer Research conference this weekend. Researchers discover drug target for incurable childhood brain cancer http://www.icr.ac.uk/press/press_archive/press_releases_2013/23672.shtml Thu, 28 Mar 2013 00:00:00 +0000 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2013/23672.shtml ICR scientists have uncovered the genetic causes of a rare but lethal form of childhood cancer – opening up the prospect of an effective treatment for the disease for the first time.